We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIZD icon
2526
VanEck BDC Income ETF
BIZD
$1.6B
$380K ﹤0.01%
+22,179
New +$379K
ACNB icon
2527
ACNB Corp
ACNB
$646M
$379K ﹤0.01%
13,518
+4,965
+58% +$140K
BTAI icon
2528
BioXcel Therapeutics
BTAI
$24.8M
$379K ﹤0.01%
+781
New +$343K
PMVP icon
2529
PMV Pharmaceuticals
PMVP
$57.1M
$379K ﹤0.01%
+12,716
New +$406K
SLCT
2530
DELISTED
Select Bancorp, Inc.
SLCT
$378K ﹤0.01%
21,921
-26,327
-55% -$425K
VCRA
2531
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$377K ﹤0.01%
+8,248
New +$368K
FPXI icon
2532
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$261M
$376K ﹤0.01%
+5,867
New +$395K
OESX icon
2533
Orion Energy Systems
OESX
$38.9M
$375K ﹤0.01%
9,651
+8,488
+730% +$392K
CSIQ icon
2534
Canadian Solar
CSIQ
$932M
$373K ﹤0.01%
+10,800
New +$411K
DTM icon
2535
DT Midstream
DTM
$13.9B
$373K ﹤0.01%
+8,050
New +$352K
UBX
2536
DELISTED
Unity Biotechnology
UBX
$373K ﹤0.01%
12,412
+8,418
+211% +$297K
AON icon
2537
Aon
AON
$80.6B
$371K ﹤0.01%
1,298
-350,496
-100% -$94.2M
QTNT
2538
DELISTED
Quotient Limited Ordinary Shares
QTNT
$370K ﹤0.01%
+3,956
New +$494K
HDSN
2539
Hudson Technologies
HDSN
$246M
$369K ﹤0.01%
+104,426
New +$349K
LXFR icon
2540
Luxfer Holdings
LXFR
$456M
$368K ﹤0.01%
+18,759
New +$387K
AVPT icon
2541
AvePoint
AVPT
$2.76B
$366K ﹤0.01%
+43,165
New +$430K
BCML icon
2542
BayCom
BCML
$335M
$366K ﹤0.01%
19,697
-6,247
-24% -$112K
XPEL icon
2543
XPEL
XPEL
$1.22B
$366K ﹤0.01%
4,824
-23,681
-83% -$1.95M
BMY icon
2544
Bristol-Myers Squibb
BMY
$129B
$365K ﹤0.01%
6,158
-51,576
-89% -$3.4M
RNAM
2545
DELISTED
Avidity Biosciences
RNAM
$365K ﹤0.01%
14,833
FSLY icon
2546
Fastly Inc
FSLY
$3.24B
$364K ﹤0.01%
+8,991
New +$415K
GTN icon
2547
Gray Television
GTN
$437M
$364K ﹤0.01%
+15,980
New +$354K
VINC
2548
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$363K ﹤0.01%
1,122
-1,296
-54% -$378K
CMCT
2549
Creative Media & Community Trust
CMCT
$8.37M
$362K ﹤0.01%
2
+1
+100% +$191K
NWN icon
2550
Northwest Natural Holdings
NWN
$2.15B
$362K ﹤0.01%
+7,882
New +$403K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.